Financials
Income statement
Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 31.5B | 19.2B | 15.6B | 20.3B |
Cost of revenue | 9.2B | 8.5B | 8.1B | 8.6B |
Gross profit | 22.4B | 10.7B | 7.5B | 11.7B |
Operating expense | ||||
Research & development | 122.9M | 123.1M | 103.3M | 551.2M |
Selling general and admin | 795.4M | -109.4M | 321.9M | -472.4M |
Other operating expenses | 709.2M | 466.8M | 276.4M | 423.1M |
Operating income | 21.2B | 9.8B | 6.8B | 10.1B |
Non operating interest income | ||||
Income | 50.8M | 52.5M | -52.0M | 66.5M |
Expense | 2.9B | 2.8B | 2.9B | 3.2B |
Other income expense | — | — | — | — |
Pretax income | 19.6B | 8.8B | 4.8B | 7.0B |
Tax provision | 2.8B | 1.3B | 681.5M | 908.9M |
Net income | 16.8B | 7.5B | 4.1B | 6.1B |
Basic EPS | — | — | 0.2 | — |
Diluted EPS | — | — | 0.2 | — |
Basic average shares | — | — | 24.5B | — |
Diluted average shares | — | — | 24.5B | — |
EBITDA | 22.4B | 11.5B | 7.7B | 10.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -131.5M | -111.8M | -109.3M | -341.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |